Web24 sep. 2024 · MENLO PARK, Calif., Sept. 24, 2024 /PRNewswire/ -- IONpath, Inc., the leader in high-definition spatial proteomics, today announced the close of a $18 million … Web1 jan. 2014 · 天眼查为您提供IONpath公司概况:IONpath, Inc.不断推动组织成像技术发生革命性的变化,力求加速医学发现和改善人类健康。该公司的MIBIscope™系统所采用的多 …
Ionpath on LinkedIn: #aacr23 #tme #oncology #immunology # ...
Web28 sep. 2024 · IONpath, Inc., a Menlo Park, Calif.-based developer of high-definition spatial proteomics, closed a $18m Series B financing. The round was led by Samsara … Web11 mei 2024 · IonPath, Inc. announced that it has received $123.740413 million in funding from Thermo Fisher Scientific Inc. 05/11/2024 EDT On May 11, 2024, IonPath, Inc. closed the transaction. The transaction included participation from new investor, Thermo Fisher Scientific Inc. © S&P Capital IQ 2024 dictionary get all keys
IONpathが医薬品の発見・開発プログラムに役立つ多重化組織分 …
WebIonpath provides Multiplexed Ion Beam Imaging (MIBI™) technology enabling scientists to perform high-definition spatial proteomics giving them new insights on diseases to … Web17 jun. 2024 · MENLO PARK, Californie, 17 juin 2024 /PRNewswire/ -- IONpath, Inc., le leader dans le domaine de l'analyse et l'imagerie tissulaire spatiale multiplexée, a annoncé aujourd'hui la nomination de... WebIonpath provides Multiplexed Ion Beam Imaging (MIBI™) technology enabling scientists to perform high-definition spatial proteomics giving them new insights on diseases to enhance pharmaceuticals... city controller office